OOIR: Observatory of International Research

Papers

(The median citation count of Clinical Microbiology Reviews is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Extracutaneous sporotrichosis	337
Wild-type distributions of minimum inhibitory concentrations and epidemiological cut-off values—laboratory and clinical utility	181
Transmission of Infections during Cardiopulmonary Resuscitation	170
Vaccines and monoclonal antibodies to prevent healthcare-associated bacterial infections	144
A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders	118
Erratum for Nyaruaba et al., “Digital PCR Applications in the SARS-CoV-2/COVID-19 Era: a Roadmap for Future Outbreaks”	116
Antibiotic tolerance among clinical isolates: mechanisms, detection, prevalence, and significance	108
The long reach of influenza and other respiratory viruses: from acute epithelial injury to post-viral lung disease	103
Progression of antibiotic resistance in Neisseria meningitidis	98
Membrane Technology for Rapid Point-of-Care Diagnostics for Parasitic Neglected Tropical Diseases	97
Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options	92
Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant	89
HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus	88
Intestinal biofilms: pathophysiological relevance, host defense, and therapeutic opportunities	83
Viral infections and pathogenesis of glaucoma: a comprehensive review	78
Emerging hybrid shigatoxigenic and enteropathogenic Escherichia coli serotype O80:H2 in humans and calves	78
Henipaviruses: epidemiology, ecology, disease, and the development of vaccines and therapeutics	73
Non- faecium non- faecalis enterococci: a review of clinical manifestations, virulence factors, and antimicrobial resistance	69
Evolutionary Pathways and Trajectories in Antibiotic Resistance	69
Review of BCG immunotherapy for bladder cancer	67
Congenital Syphilis: a Review of Global Epidemiology	64
Clonorchiasis and opisthorchiasis: epidemiology, transmission, clinical features, morbidity, diagnosis, treatment, and control	62
Neisseria gonorrhoeae vaccines: a contemporary overview	60
Extrapolation and comparison of West Nile virus- and Usutu virus-associated neurological diseases in humans: linking pathology to clinical symptoms	59
Bacillus cereus Invasive Infections in Preterm Neonates: an Up-to-Date Review of the Literature	57

Bacterial and fungal infections in persons who inject drugs	54
Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease	52
BCG therapy in bladder cancer and its tumor microenvironment interactions	52
Diagnosis, Management, and Future Control of Cholera	52
Rapid and accurate testing for urinary tract infection: new clothes for the emperor	50
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes	50
The mRNA Vaccine Technology Era and the Future Control of Parasitic Infections	49
Aspergillus terreus Species Complex	48
Trained Immunity as a Preventive Measure for Surgical Site Infections	48
Agnostic Sequencing for Detection of Viral Pathogens	47
Immunosuppressant imprecision: multidirectional effects on metabolism and microbiome	47
Harnessing the host response for precision infectious disease diagnosis	46
Artemisinin-resistant malaria	44
Lyme borreliosis in Brazil: a critical review on the Baggio–Yoshinari syndrome (Brazilian Lyme-like disease)	43
Editorial Board	42
COVID-19 therapeutics	39
2021 Acknowledgment of CMR Reviewers	39
The challenges of difficult-to-treat Acinetobacter infections	38
Pneumocystis jirovecii pneumonia in people living with HIV: a review	38
Pathogenesis of viral infections during pregnancy	38
An updated list of eumycetoma causative agents and their differences in grain formation and treatment response	36
Challenges for global antibiotic regimen planning and establishing antimicrobial resistance targets: implications for the WHO Essential Medicines List and AWaRe antibiotic book dosing	36
Human toxocariasis	34
SARS-CoV-2 Antiviral Therapy	34
Invasive fusariosis	32
Klebsiella oxytoca Complex: Update on Taxonomy, Antimicrobial Resistance, and Virulence	30
Osteoarticular Mycoses	30
Editorial Board	30
Editorial Board	30
Natural-Product-Based Solutions for Tropical Infectious Diseases	30
Candidate Phyla Radiation, an Underappreciated Division of the Human Microbiome, and Its Impact on Health and Disease	28
Narrative review on bacteria-derived metabolites in the pathogenesis of ulcerative colitis	28
Updated Review onNocardiaSpecies: 2006–2021	28
Clinical Microbiology Reviews : a 21st century vision	23
The endothelium at the interface between tissues and Staphylococcus aureus in the bloodstream	22
Fungal Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and Management	22
Host Immunity and Immunization Strategies for Clostridioides difficile Infection	22
Machine Learning for Antimicrobial Resistance Prediction: Current Practice, Limitations, and Clinical Perspective	22
Skin microbiota in atopic dermatitis: victim or executioner?	21
Role of the intestinal microbiota in contributing to weight disorders and associated comorbidities	21
Masks and respirators for prevention of respiratory infections: a state of the science review	19
Surveillance and prevention of infection in clinical xenotransplantation	19
Current perspectives in the epidemiology and control of lymphatic filariasis	18
The American Society for Microbiology’s evidence-based laboratory medicine practice guidelines for the diagnosis of bloodstream infections using rapid tests: a systematic review and meta-analysis	18
Prion Dissemination through the Environment and Medical Practices: Facts and Risks for Human Health	17
Correction for Moreland et al., “Rapid and accurate testing for urinary tract infection: new clothes for the emperor”	17
Advancements and challenges in antifungal therapeutic development	17
A call for the United States to continue investing in science	17
Scedosporiosis and lomentosporiosis: modern perspectives on these difficult-to-treat rare mold infections	16
2023 Acknowledgment of CMR Reviewers	16

Human Listeriosis	16
Streptococcus pneumoniae β-lactam resistance: epidemiological trends, molecular drivers, and innovative control strategies in the post-pandemic era	16
Neurological complications caused by SARS-CoV-2	15
Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies	15
Genotypic Resistance Testing of HIV-1 DNA in Peripheral Blood Mononuclear Cells	14
Recent advances in the influenza virus vaccine landscape: a comprehensive overview of technologies and trials	13
American Society for Microbiology evidence-based laboratory medicine practice guidelines to reduce blood culture contamination rates: a systematic review and meta-analysis	13
2024 Acknowledgment of CMR Reviewers	12
Worldwide Control and Management of Chagas Disease in a New Era of Globalization: a Close Look at Congenital Trypanosoma cruzi Infection	12
Monkeypox Virus Infections in Humans	12
Recent advances in therapeutic probiotics: insights from human trials	10
Genital cutaneous candidiasis versus chronic recurrent vulvovaginal candidiasis: distinct diseases, different populations	10
Laboratory detection of carbapenemases among Gram-negative organisms	10